NUP214 and acute lymphoblastic leukemia: It is related to resistance to glucocorticoids and chemotherapy; however, the reported prognosis of T-ALL with <i>SET-CAN/NUP214</i> fusion is diverse, and the optimal treatment option remains undetermined.